A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics

Author： Hanlon C.A. Niezgoda M. Shankar V. Hong S.N. Koprowski H. Rupprecht C.E.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.15, Iss.2, 1997-02, pp. : 140-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the susceptibility of the red fox (Vulpes vulpes) to a vaccinia-rabies recombinant virus and to cowpox virus

By Boulanger D. Brochier B. Crouch A. Bennett M. Gaskell R.M. Baxby D. Pastoret P.-P.

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 215-219

Elsevier

Access to resources Recommend Favorite

Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

By Nishikawa Y. Inoue N. Xuan X. Nagasawa H. Igarashi I. Fujisaki K. Otsuka H. Mikami T.

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1381-1390

Elsevier

Access to resources Recommend Favorite

Rabies vaccination: comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines

By Lodmell D.L. Ewalt L.C.

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2394-2398

Elsevier

Access to resources Recommend Favorite

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S. Shors S.T. Murphy B.R. Moss B.

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite

Innocuity studies of SAG-2 oral rabies vaccine in various Zimbabwean wild non-target species

By Bingham J. Schumacher C.L. Aubert M.F.A. Hill F.W.G. Aubert A.

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 937-943

Elsevier

Access to resources Recommend Favorite